Sector ratings Dr. Reddy's Laboratories Limited

Equities

Market Closed - Bombay S.E. Other stock markets 05:00:50 2026-01-16 am EST			5-day change	1st Jan Change
1,175.55 ^INR	-0.92%		-2.80%	-7.51%

Jan. 16	Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Up Over 2% for Week	MT
Jan. 14	Dr. Reddy's Laboratories Ltd. Announces the Launch of Over-The-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
DR. REDDY'S LABORATORIES LIMITED	10.79B		A
ELI LILLY AND COMPANY	930B		A
JOHNSON & JOHNSON	527B		BBB
ABBVIE INC.	379B		AA
ROCHE HOLDING AG	371B		AA
ASTRAZENECA PLC	292B		A
MERCK & CO., INC.	270B		A
NOVARTIS AG	276B		AAA
NOVO NORDISK A/S	268B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	155B		AAA
PFIZER INC.	146B		BBB
SANOFI	113B		A
BRISTOL-MYERS SQUIBB COMPANY	112B		A
VERTEX PHARMACEUTICALS INCORPORATED	112B		AA
GSK PLC	97.55B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	85.93B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	59.15B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	50.71B		AA
Average	224.86B		AA
Weighted average by Cap.			AA